General

Life After Oncology

Professor Michael Baum, Professor Emeritus of Surgery & Visiting Professor of Medical Humanities, University College, London, UK; Email: baum.michael3@gmail.com Q: You have recently decided to “withdraw from the field” after a distinguished multi-decade career in Surgical Oncology. Many of our readers will confront a similar choice. How do you see your life evolving from here […]

Huge Progress in Palliative Care

Diane E. Meier, MD, FACP, Director, Center to Advance Palliative Care; Professor of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai; New York, NY; Email: diane.meier@mssm.edu Follow Diane Q: You wrote in MedGenMed in 2007 that palliative care was the job of all hospitals (MedGenMed 2007; 9(3) 6. July 7. PMCID:PMC2100088). In […]

How I Survive Cancer

Erin Maloney, Intrepid explorer, Amateur photographer, Aspiring leader; Toronto, ON; Email: erinLmaloney@gmail.com Q: You have recently disclosed that you have had a diagnosis of cancer and described your experience in some detail on Medium. What does it mean to you to be a “Cancer Survivor”? A: Calling myself a survivor sometimes feels like an exaggeration. […]

Who Owns Patient Data in Clinical Research?

Charlotte J. Haug, MD, PhD, MSc, International Correspondent, New England Journal of Medicine; Senior Scientist, SINTEF Techology and Society; Adjunct Affiliate, Stanford Health Policy; Oslo, Norway; Email: charlottejohanne@gmail.com Follow Charlotte Q: Many people are coming to believe that active patient participation will be a key to more rapid movement forward in cancer research. Data sharing […]

Nicotine Addiction: Harm Reduction by E-cigarettes and Snus

Joel L. Nitzkin, MD, Public Health Physician, New Orleans, LA Email: jlnitzkin@gmail.com Follow Joel Q: Tobacco smoking remains the most preventable primary form of cancer causation in Americans. A recent Medscape column urged that harm reduction for confirmed nicotine addicts is the kindest and most effective strategy. How can products like “snus” be helpful? A: […]

Pharmacogenomics for Clinical Use of Cannabis

Saeed K. Alzghari, M.S., M.B.A. (HOM), Pharm.D., BCPS, Director of Clinical Pharmacy, Gulfstream Genomics, LLC., Dallas, TX; Email: salzghari@gulfdiagnostics.com Q: Proper use of Pharmacogenomics can inform better patient care in many potential ways. Pain relief by use of Cannabis instead of opioids shows substantial promise. How do you think pharmacogenomic study could guide intelligent clinical […]

Public Health Personalized Medicine

Gualberto Ruaño, MD, PhD, President, Genomas Inc.; Medical Director, Laboratory of Personalized Health; Hartford, CT; Email: g.ruano@genomas.net Q: Public participation by contributing specimens to assess personal genomic information is rapidly increasing. How might this expansion of testing become actually useful for the health of the public? A: The fields of public health and medicine share […]

Psychiatric Drug Use by Medical Students and Residents

Pamela Wible, MD, Founder of the Ideal Medical Care movement; Author of Physician Suicide Letters—Answered; Family medicine practitioner in Oregon; Follow Pamela Q: Medical students and residents are among the most important human resources in the United States. Yet we lose many during training due to suicide. Have you information you can share with our […]

The Worst Phony Cancer Cures

Stephen Barrett, MD, Retired Psychiatrist; Medical Editor for Quackwatch.org and 24 other consumer-protection Web sites; Publisher for Consumer Health Digest; Chapel Hill, NC; Email: sbinfo@quackwatch.org Q: Who tops your list as the most brazen promoters of phony cancer cures in the past 25 years? A: Three people come to mind: Gregory Caplinger, Hulda Clark, and […]

Nordic Country Tobacco Control

Astrid Nylenna, MD, Acting Head of Department, Department of Global Health, Norwegian Directorate of Health, Oslo, Norway; Email: Astrid.Nylenna@helsedir.no Follow Astrid Q: Norway has been very active in tobacco control and prevention with some success. To what do you attribute the success Norway has had and are there any lessons from other Scandinavian countries that […]